Paravertebral Block for Mastectomy With Immediate Reconstruction
- Disease/Condition
- Postoperative Pain
- Drug/Device/Intervention
- Paravertebral block
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- CHU de Quebec-Universite Laval
- Phase
- N/A
- Start date
- Mar 01, 2024
- End date
- Dec 01, 2025
- Enrollment
- 60 participants
Evaluation of postoperative pain using the BPI
Following a mastectomy, patients may develop chronic pain, called post-mastectomy pain
 syndrome (PMPS). This syndrome manifests itself as complex neuropathic pain that seems linked
 to nerve damage suffered either during surgery, during healing or by nervous system
 dysfunction. However, the exact pathophysiology remains unknown. Typically, the pain is
 located on the ipsilateral side of the surgery and projects to the anterior thorax to the
 lateral thorax and may affect the proximal part of the arm. This pain persists for more than
 three months following the procedure and has the characteristics of neuropathic pain: burning
 sensation, tingling, electric shock, hyperalgesia, etc. The prevalence of PMDS varies between
 2% and 78%; this disparity comes from the fact that there are no clear criteria in the
 literature for making the diagnosis. One of the risk factors for developing PMDS is the
 presence of acute pain immediately postoperatively.
 
 The main objective of this study is to compare two analgesic modalities, namely BPV (study
 modality) and usual analgesia (control modality), in patients undergoing total mastectomy
 with immediate reconstruction under general anesthesia with the aim of to evaluate their
 functional pain score at 24, 48 and 72 hours following the surgical procedure.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06276257
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06276257 through Pure Global AI's free database. This phase not specified trial is sponsored by CHU de Quebec-Universite Laval and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.